Peri Alessandro
a Sodium Unit, Endocrinology, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio' , University of Florence, Careggi University Hospital , Florence , Italy.
Expert Rev Endocrinol Metab. 2019 Jan;14(1):13-21. doi: 10.1080/17446651.2019.1556095. Epub 2018 Dec 31.
Hyponatremia is the most frequent electrolyte disorder in hospitalised patients. Acute and severe hyponatremia may be a life-threatening situation. However, also mild and chronic hyponatremia may negatively affect the health status (i.e. gait disturbances, attention deficits, falls and fractures, and bone loss) and may increase the risk of death. Therefore, it is of paramount importance for clinicians to have an in-depth knowledge on this topic, in order to appropriately manage patients affected by hyponatremia.
This review will cover different areas related to this electrolyte disorder. Because many pathologic conditions may be associated with hyponatremia, thorough investigations have to be performed in order to establish the underlying etiology. To establish the cause of hyponatremia is of great importance, because an appropriate therapeutic strategy is strictly dependent on a correct diagnosis. A description of the different available therapeutic approaches for the correction of hyponatremia, including vaptans, will follow.
Undoubtedly, the studies that have been published in recent years and the introduction of vaptans in clinical practice have contributed to increase the awareness on hyponatremia among clinicians. Nevertheless, additional studies are needed in order to clarify some partially uncovered areas.
低钠血症是住院患者中最常见的电解质紊乱。急性重度低钠血症可能危及生命。然而,轻度和慢性低钠血症也可能对健康状况产生负面影响(如步态障碍、注意力缺陷、跌倒和骨折以及骨质流失),并可能增加死亡风险。因此,临床医生深入了解这一主题至关重要,以便妥善处理低钠血症患者。
本综述将涵盖与这种电解质紊乱相关的不同领域。由于许多病理状况可能与低钠血症相关,因此必须进行全面调查以确定潜在病因。确定低钠血症的病因非常重要,因为合适的治疗策略严格依赖于正确的诊断。接下来将描述纠正低钠血症的不同可用治疗方法,包括血管加压素受体拮抗剂。
毫无疑问,近年来发表的研究以及血管加压素受体拮抗剂在临床实践中的应用提高了临床医生对低钠血症的认识。然而,仍需要更多研究来阐明一些尚未完全揭示的领域。